Dr. Bille will oversee manufacturing scale-up for broad-spectrum influenza vaccine candidate OVX836 currently in Phase 2 clinical testingCompany achieved accreditation from Belgian authorities for OVX836 batch quality control laboratory in Liège Science ParkLYON, France (BUSINESS WIRE) Osivax, a biopharmaceutical.
Osivax Appoints Vincent Bille as Chief Manufacturing Officer and Announces Manufacturing Progress for OVX836 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.